The Flexibility of Compliance and What If …? Part 2/2 - METTLER TOLEDO
Virtuálne
Seminár
Naplánované

The Flexibility of Compliance and What If …? Part 2/2

Virtuálne
Seminár
Naplánované

Handling Risks and Errors in Pharma Records

Bob McDowall, experienced auditor, consultant and author of many books and papers around Electronic Records and Data Integrity Compliance for Pharmaceutical Industries.
Bob McDowall, experienced auditor, consultant and author of many books and papers around Electronic Records and Data Integrity Compliance for Pharmaceutical Industries.

Handling Risks and Errors in Pharma Records - there should be procedures to stay compliant. With their focus on Data Integrity, regulation authorities are ever pushing the pharmaceutical industries towards electronic records. The number of FDA warning letters with citations of data integrity violations reveal that not every pharma company interprets the rules correctly and with an acceptable risk management policy.

Conservative practices might overlook the dynamic of regulations and might end in incompliance just because the interpretation of rules have evolved.

Cost of webinar: the participation is free of charge.

To learn more about the ways to interpret Pharma Regulations.

Bob McDowall and Christoph Jansen
ca. 50 minutes
Fri Nov 26 2021 08:00 +0000 [ English ]
Fri Nov 26 2021 16:00 +0000 [ English ]

In this Webinar we will discuss with Bob McDowall:

Part 2/2

  • What are the action items of violations and findings?
  • Unofficial testing
  • What do you recommend in terms of software updates?
  • What is the best time to report issues?
  • Cost of compliance
  • Cost efficient CSV with platform solutions
 

Cost of webinar: the participation is free of charge.



Táto stránka nie je optimalizovaná pre Váš prehliadač. Zvážte prosím použitie iného prehliadača alebo upgradujte svoj prehliadač na najnovšiu verziu pre lepšie zobrazenie.